Can a COVID Infection Trigger GBS?

November 1, 2021

Guillain-Barré Syndrome (GBS) is an autoimmune neurological condition that results in damaged nerve cells. Cases of GBS have been verified by the FDA as a rare side effect to certain vaccines, including Johnson & Johnson’s COVID-19 vaccine. GBS has also been known to develop after certain respiratory or gastrointestinal viral infections and may be triggered by a COVID-19 infection. 

The International GBS Outcome Study is an ongoing prospective observational cohort study with GBS patients. Data from January 30 – May 30, 2020, was collected and analyzed to investigate the connection between GBS and COVID-19 infections. 49 GBS patients were included and 48 completed questionnaires assessing clinical suspicion for SARS-CoV-2. Of this cohort, 8 patients (16%) had a confirmed previous SARS-CoV-2 infection, and 3 patients (6%) had a probable SARS-CoV-2 infection.

The median age of patients within the cohort was 56 years; the median age of patients with a confirmed or probable COVID-19 infection was 63 years. 73% of GBS patients with a COVID-19 infection presented increased inflammatory markers; 64% had facial palsy. 

Overall, 22% of GBS patients had a preceding COVID-19 infection. It was not determined whether recovery was more difficult for the patients versus other GBS patients, especially when factoring severity of COVID-19 infection. Researchers emphasized that analysis from the first four months of the pandemic did not show an increase in GBS cases compared to previous years. Therefore, while Covid-19 infections may trigger the development of GBS, a stronger causal relationship has yet to be determined. “Should SARS-CoV-2 indeed be able to trigger GBS, our data are consistent with a post-infectious disease mechanism rather than direct viral invasion, as the time between the onset of SARS-CoV-2 symptoms and GBS ranged from 2 to 3.5 weeks.”





Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.